STAGE IVA LUNG CANCER AJCC V8
Clinical trials for STAGE IVA LUNG CANCER AJCC V8 explained in plain language.
Never miss a new study
Get alerted when new STAGE IVA LUNG CANCER AJCC V8 trials appear
Sign up with your email to follow new studies for STAGE IVA LUNG CANCER AJCC V8, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New cocktail of immune drugs shows promise for tough lung cancer
Disease control CompletedThis study tested a combination of two immunotherapy drugs (durvalumab and tremelimumab) plus a targeted therapy (selumetinib) in 40 adults with advanced non-small cell lung cancer that had returned or spread. The goal was to find the best dose and see if the combo could shrink t…
Matched conditions: STAGE IVA LUNG CANCER AJCC V8
Phase: PHASE1, PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 04, 2026 16:21 UTC
-
New combo therapy targets Drug-Resistant lung cancer
Disease control CompletedThis early-phase trial tested two experimental drug combinations (osimertinib plus alisertib or sapanisertib) in 37 adults with advanced EGFR-mutant non-small cell lung cancer that no longer responded to osimertinib alone. The main goals were to find the safest dose and check for…
Matched conditions: STAGE IVA LUNG CANCER AJCC V8
Phase: PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Apr 24, 2026 16:19 UTC
-
New program aims to boost resilience in older lung cancer patients
Symptom relief CompletedThis study tested a supportive care program for adults aged 60 and older with advanced lung cancer. The program combined physical therapy and relaxation exercises to help improve physical function and emotional well-being during cancer treatment. About 100 participants took part …
Matched conditions: STAGE IVA LUNG CANCER AJCC V8
Phase: NA • Sponsor: Ohio State University Comprehensive Cancer Center • Aim: Symptom relief
Last updated May 17, 2026 02:16 UTC
-
Cancer moonshot study banks tissue to unlock genetic secrets
Knowledge-focused CompletedThis study collected blood and tumor tissue from 64 people with advanced or treatment-resistant cancers. Researchers stored these samples to study how genes affect cancer growth and response to therapy. The goal is to better understand why some cancers stop responding to treatmen…
Matched conditions: STAGE IVA LUNG CANCER AJCC V8
Sponsor: National Cancer Institute (NCI) • Aim: Knowledge-focused
Last updated May 17, 2026 02:02 UTC